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Operative management of symptomatic, metachronous
carotid body tumors involving the skull base and its
neurological sequelae
Roberto G. Aru, MD,a Rony K. Aouad, MD,b Justin F. Fraser, MD,c Amanda M. Romesberg, DO,d
Kevin W. Hatton, MD,e and Sam C. Tyagi, MD,a Lexington, Ky

ABSTRACT
A 44-year-old morbidly obese woman with a history of right carotid body tumor (CBT) resection presented with a
symptomatic, nonfunctional, left Shamblin-III CBT. Abutment of the skull base precluded distal internal carotid artery
control for arterial reconstruction, favoring parent vessel sacriﬁce after an asymptomatic provocative test. She underwent
CBT resection with anticipated sacriﬁce of cranial nerves X and XII and the common carotid artery and its branches,
developing baroreceptor failure syndrome and sequelae of cranial nerve sacriﬁce. When facing a symptomatic, metachronous CBT abutting the skull base, upfront operative intervention with adjuvant radiation for residual tumor optimizes
curative resection. (J Vasc Surg Cases Innov Tech 2021;7:378-81.)
Keywords: Carotid body tumor; Metachronous carotid body tumor; Cranial nerves deﬁcit; Baroreceptor failure syndrome;
Multidisciplinary care

CASE REPORT

successful because distal ICA control was prohibitive for arterial

A morbidly obese 44-year-old woman presented with painful

reconstruction. After successful balloon test occlusion (Fig 2), the

swelling in her left upper neck. She denied recent trauma, to-

ICA and ECA branches were embolized with Amplatzer plugs

bacco abuse, or family history of paragangliomas. She under-

(St. Jude Medical, St. Paul, Minn) and Target 360 soft and ultra

went excision of a right Shamblin-III carotid body tumor (CBT)

coils (Stryker, Kalamazoo, Mich), respectively. The patient was

with greater saphenous vein interposition graft at 17 years old.

placed on aspirin 81 mg monotherapy, and after 3 weeks, she

She was lost to follow-up and did not have surveillance duplex
imaging, succinate dehydrogenase levels, or genetic evaluation.

remained asymptomatic without cerebrovascular events. She
then underwent a transcervical CBT resection with anticipated

On physical examination, she had a tender left neck mass; cra-

sacriﬁce of CNs X and XII, the left internal jugular vein, and the

nial nerves (CNs) were intact, including CN X via ﬂexible ﬁberop-

common carotid artery and its branches (Fig 3). Estimated blood

tic laryngoscopy. The lesion was nonfunctional with a normal

loss was 1 L. Pathology conﬁrmed the diagnosis of a CBT. Intrao-

serum normetanephrine level. Imaging (Fig 1) demonstrated a

peratively, she developed baroreceptor failure syndrome (BFS)

6.2 cm, left, Shamblin-III CBT abutting the skull base. The patient

with hypertensive crisis evidenced by systolic blood pressure

declined radiation therapy because of claustrophobia and elec-

up to 220 mm Hg. She required intravenous antihypertensive

ted surgery despite the risks. A multidisciplinary discussion
among Vascular Surgery, Otolaryngology, and Neurosurgery

and heart rate control medications over the next week, while
she was transitioned to oral equivalents with a gradual wean

established that balloon test occlusion would determine the

to carvedilol. Further complications included acute respiratory

need for internal carotid artery (ICA)-external carotid artery

failure due to aspiration requiring reintubation, dysphonia due

(ECA) bypass, with anticipation of parent vessel sacriﬁce if

to unilateral vocal cord paralysis managed with vocal cord
augmentation that restored her voice, and dysphagia requiring
gastrostomy-tube placement. On postoperative day 41, she was
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discharged home with continued oral treatment for BFS. She

of Radiology, and the Division of Critical Care Medicine, Department of Anes-

has been recovering slowly but remains gastrostomy-tube
dependent, and she is still undecided regarding adjuvant radia-

thesiology,e University of Kentucky.

tion
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d
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therapy
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despite

recommendations.
The patient provided written informed consent for patient information and images to be published.
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DISCUSSION

manuscript for which they may have a conﬂict of interest.

CBTs are the most common head and neck paragangliomas.1 This rare pathology arises from the periadventitia of the carotid bifurcation. The carotid body maintains
homeostasis of carbon dioxide, oxygen, and pH, whereas
carotid baroreceptors in the carotid sinus regulate blood
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Fig 1. 3D segmentation of a computed tomography
angiography of the neck in left posterior oblique projection demonstrates a large vascular mass (purple) abutting
the skull base and splaying the internal carotid artery (ICA)
(thick arrow) and external carotid artery (ECA) (thin arrow).
The splayed conﬁguration of the ICA and ECA resembles a
lyre.

pressure.2 Symptomatic CBTs mandate operative resection that may be associated with signiﬁcant morbidity.
Bilateral synchronous CBTs occur in 7% to 11% of CBTs
that can require staged bilateral resection, predisposing
to BFS.2,3 Our patient had a symptomatic metachronous,
benign, Shamblin-III CBT abutting the skull base. She
declined radiation therapy because of claustrophobia
and elected for surgical intervention despite the risks,
especially related to nerve sacriﬁce. She underwent preoperative embolization with subsequent extensive resection and carotid ligation without reconstruction,
resulting in anticipated, permanent, and unilateral vagus
and hypoglossal nerve deﬁcits as well as transient hypertensive crisis due to BFS. We approach CBTs with a multidisciplinary approach in order to optimize outcomes as
described by Mohebali et al.4 Herein, we discuss our
complications in this complex case as well as preoperative decision-making.
Cranial nerve injury (CNI) is a common complication after surgical resection of CBTs, resulting in signiﬁcant
morbidity in up to 40% of patients.5-7 Patients most
commonly experience deﬁcits of the vagus (6%), hypoglossal (6%), and accessory (3%) nerves as well as the
sympathetic chain (3%).1 Clinical implications include
hoarseness, dysphagia, dysgeusia, unilateral neck weakness, and Horner’s syndrome. The Shamblin classiﬁcation
classically stratiﬁes the degree of tumor encasement of
the carotid arteries in order to predict the need for carotid reconstruction; a higher Shamblin classiﬁcation is

associated with greater risk of CNI.8 Other risk factors
include bilateral resection, number of lymph nodes
removed, distance to base of the skull, tumor volume,
and estimated blood loss.2,8,9 In our patient, her
Shamblin-III CBT abutting the skull base encased the
vagus and hypoglossal nerves, prohibiting preservation
despite initial identiﬁcation and preservation during surgery. Regarding dysphagia and dysphonia after vagus
nerve sacriﬁce, young patients recover well with minimal
dysfunction after vocal cord augmentation and therapy
by the speech and swallow team. Furthermore, unilateral
hypoglossal nerve paralysis has minimal effect on speech
and swallowing as the contralateral nerve is enough for
this function, despite the expected hemitongue atrophy.
BFS is a well-documented sequela of bilateral CBT
resection due to unopposed sympathetic brainstem signals from bilateral baroreceptor denervation.10,11 Headache, anxiety, hypertension, and tachycardia classically
characterize this morbidity,2,8,10-12 and its spectrum
ranges from hypertensive crisis to volatile hypertension
and orthostatic tachycardia.3 Hypertensive crisis develops acutely after bilateral resection with signiﬁcant
risk of a cerebrovascular event; volatile hypertension
and orthostatic tachycardia are exceedingly more common presentations of BFS with a more gradual onset
and more mild and permanent symptoms. A staged
approach to resection of synchronous, bilateral tumors
minimizes the incidence of this pathology, ranging
from 0% to 16%.2,12 Management typically includes clonidine and beta-blockers, counteracting the uninhibited
sympathetic outﬂow.3,10 In our case, an antihypertensive
infusion acutely controlled the perioperative hypertensive crisis with gradual postoperative transition to oral
antihypertensive and beta-blockade.
Management of metachronous, Shamblin-III CBTs
abutting the skull base is an individualized decision as
no standardized treatment algorithm exists. Treatment
modalities include deﬁnitive radiation (XRT), neoadjuvant XRT with resection, and resection with adjuvant
XRT for symptomatic CBTs, while observation is appropriate in asymptomatic lesions.10 We discussed XRT
given the signiﬁcant anticipated morbidity with resection. XRT solely halts growth, but data on symptom control are lacking. Furthermore, there is a risk of secondary
malignancies such as sarcomas. Continued symptoms
after XRT mandates salvage surgical resection that may
be more complex, and residual tumor after XRT is not
appropriate for additional irradiation. Given the patient’s
claustrophobia in the setting of a large and symptomatic
lesion, we felt that resection with adjuvant XRT for anticipated, residual tumor was the best treatment modality.
This rationale guided our multidisciplinary decision for
surgical resection in a young patient with a symptomatic
CBT.
Tumor involvement of the ICA at the jugular foramen
complicates CBT resection as it precludes ICA
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Fig 2. A, Digital subtraction angiography (DSA) imaging with lateral view of the carotid system and carotid body
tumor (CBT) preembolization of the internal (ICA) and external carotid arteries (ECA). B, Subtracted DSA imaging with lateral view post embolization of the ICA and ECA. C, Nonsubtracted DSA imaging with lateral view
post embolization of the ICA and ECA.

Fig 3. Operative ﬁeld during (A) and after (B) resection of left carotid body tumor (CBT).

reconstruction. Its incidence is rare in the setting of bilateral CBTs; two case series (n ¼ 306) describe this pathology only twice (<0.01%).1,13 A described preoperative
evaluation of neurovascular insufﬁciency involves manual
compression of the common carotid artery for 30 minutes.7 In our patient, a multidisciplinary approach
assessed adequate cerebrovascular perfusion with ICA
balloon occlusion via a published and standard technique.14 Imaging conﬁrmed patency of the contralateral
autologous interposition graft. The patient underwent
uncomplicated ICA and ECA coil embolization with subsequent carotid ligation without reconstruction. In

addition, preoperative embolization in CBTs is an adjunct
to decrease intraoperative blood loss and CNI, although
its efﬁcacy is controversial.15,16

CONCLUSIONS
Bilateral CBTs are a complex and rare pathology with
high risk of operative morbidity. A symptomatic, metachronous, Shamblin-III CBT abutting the skull base in a
young patient is a rare clinical scenario. Operative intervention requires thorough preoperative planning and a
multidisciplinary approach, and surgical complications
must be thoroughly discussed preoperatively.
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